Provided by Tiger Fintech (Singapore) Pte. Ltd.

REMEGEN

98.150
+10.15011.53%
Volume:12.30M
Turnover:1.18B
Market Cap:55.36B
PE:-32.79
High:100.800
Open:88.800
Low:87.500
Close:88.000
52wk High:100.800
52wk Low:10.200
Shares:564.00M
HK Float Shares:209.00M
Volume Ratio:1.53
T/O Rate:5.89%
Dividend:- -
Dividend Rate:- -
EPS(LYR):-2.993
ROE:-45.30%
ROA:-11.67%
PB:21.42
PE(LYR):-32.79
PS:24.36

Loading ...

HK Movers|HK's Pharma Shares Jumped. Medlive Up 8%; Sihuan Pharm And Junshi Bio Up 7%; Pharmaron And Fosun Pharma Up 5%

Tiger Newspress
·
Jun 03

Nomura Adjusts RemeGen's Price Target to HK$47.60 From HK$16.37, Keeps at Neutral

MT Newswires Live
·
May 23

BUZZ-RemeGen's Hong Kong shares hit 2-year peak, Nomura lifts TP on share issuance

Reuters
·
May 23

Stock Track | REMEGEN Soars 5% as Company Announces HK$806.4 Million Share Issuance

Stock Track
·
May 22

RemeGen to Raise HK$796 Million from Issuance of 19 Million H Shares

MT Newswires Live
·
May 22

Stock Track | REMEGEN Plummets 5.01% as Company Announces New Share Issuance

Stock Track
·
May 22

BRIEF-RemeGen To Issue 19 Mln H Shares, Raising HK$806.4 Mln

Reuters
·
May 22

HK Movers | HK's Biotech Shares Soar. Asymchem up 15%; Laekna up 13%; Ascletis, CanSinoBIO up 9%

Tiger Newspress
·
May 21

HK Movers | HK's Biotech Shares Soar. Cstone Pharma Soars 20%; RemeGen up 10%; Ascletis up 6%

Tiger Newspress
·
May 20

BUZZ-China Literature drops on removal from Hang Seng Tech Index; Midea, ZTO up

Reuters
·
May 19

Chinese Stocks Close Mixed on Uncertainty Following Tariff Pause

MT Newswires Live
·
May 13

RemeGen's Urothelial Carcinoma Drug Shows Positive Results in Clinical Trial; Shares Soar 8%

MT Newswires Live
·
May 13

RemeGen Gets Nod to Trial Tumor Drug; Shares Soar 8%

MT Newswires Live
·
May 13

RemeGen Gets China Nod for Marketing of Breast Cancer Drug

MT Newswires Live
·
May 12

HK Movers | HK's Biotech Shares Pull Back. Alphamab, Cstone Pharma, Ascletis down about 10%; Immuneonco, Laekna down over 9%

Tiger Newspress
·
May 12

HK Movers | Biotech Stocks Jump With ImmuneOnco up 10%

Tiger Newspress
·
Apr 24

HK Movers|HK Pharma Stocks Shined. Zai Lab Up 15%; HBM Up 10%; Remegen Up 9%; Alphamab And Wuxi Bio Up 5%.

Tiger Newspress
·
Apr 14

RemeGen to Present Results of Phase 3 Study for Generalized Myasthenia Gravis Drug

MT Newswires Live
·
Mar 18